These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 836432)

  • 21. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
    Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
    J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New method for the measurement of eosinophil migration.
    HÃ¥kansson L; Westerlund D; Venge P
    J Leukoc Biol; 1987 Dec; 42(6):689-96. PubMed ID: 2445885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides.
    Headley AD; Ganesan R; Nam J
    Bioorg Chem; 2003 Apr; 31(2):99-108. PubMed ID: 12729567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of leukocyte chemotaxis by Glu-Glu-Glu-Glu-Tyr-Pro-Met-Glu and Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gln-Gly.
    Hirata F; Notsu Y; Matsuda K; Vasanthakumar G; Schiffmann E; Wong TW; Goldberg AR
    Biochem Biophys Res Commun; 1984 Jan; 118(2):682-90. PubMed ID: 6704100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis.
    Clark RA; Gallin JI; Fauci AS
    Blood; 1979 Apr; 53(4):633-41. PubMed ID: 426911
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro.
    Spada CS; Nieves AL; Krauss AH; Woodward DF
    J Leukoc Biol; 1994 Feb; 55(2):183-91. PubMed ID: 8301215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid chemotaxins isolated from culture filtrates of Escherichia coli and from oxidized lipids.
    Sahu S; Lynn WS
    Inflammation; 1977 Mar; 2(1):47-54. PubMed ID: 367961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD11b/CD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain.
    Gross TJ; Leavell KJ; Peterson MW
    Thromb Haemost; 1997 May; 77(5):894-900. PubMed ID: 9184399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte accumulation in sparganosis: demonstration of eosinophil and neutrophil chemotactic factors from the plerocercoid of Spirometra erinacei in vivo and in vitro.
    Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
    Am J Trop Med Hyg; 1984 Jan; 33(1):138-43. PubMed ID: 6364853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives.
    Goetzl EJ; Valone FH; Reinhold VN; Gorman RR
    J Clin Invest; 1979 Jun; 63(6):1181-6. PubMed ID: 447841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phloretin is a potent inhibitor of rabbit neutrophil activation by chemotactic factors.
    Shefcyk J; Molski TF; Volpi M; Naccache PH; Sha'afi RI
    Biochim Biophys Acta; 1983 Feb; 728(1):97-102. PubMed ID: 6830775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships for some elastin-derived peptide chemoattractants.
    Castiglione Morelli MA; Bisaccia F; Spisani S; De Biasi M; Traniello S; Tamburro AM
    J Pept Res; 1997 Jun; 49(6):492-9. PubMed ID: 9266476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors.
    Anwar AR; Kay AB
    Nature; 1977 Oct; 269(5628):522-4. PubMed ID: 909604
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.